Showing results (1071-1080 of 2,037) with videos related to
Sort By:
Pageof 204
Nuklearmedizin. Nuclear Medicine|July 9, 2021
Prostate incidentaloma on 18F-fluorodeoxyglucose positron emission tomography: Diagnostic value of volumetric positron emission tomography parametersÖzlem Şahin, Buğra Kaya, Zeynep Aydın, et al.Nuklearmedizin. Nuclear Medicine|June 1, 1985
[Immediate effect of x-ray contrast media on thyroid hormone parameters]H K Beyer, B SchulzeNuklearmedizin. Nuclear Medicine|December 1, 1986
In vitro and in vivo tumor models for studies of distribution of radiolabelled monoclonal antibodies and fragmentsF Buchegger, S E Halpern, R M Sutherland, et al.Nuklearmedizin. Nuclear Medicine|February 19, 1998
[Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy]S Dunkelmann, F Rudolph, A Prillwitz, et al.Nuklearmedizin. Nuclear Medicine|February 19, 1998
[Consequences of new patient discharge guidelines on the cost structure of radioiodine therapy]M Dietlein, C J Troche, D Moka, et al.Nuklearmedizin. Nuclear Medicine|October 1, 1986
Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidineC J Edeling, P Büchler Frederiksen, J Kamper, et al.Nuklearmedizin. Nuclear Medicine|October 1, 1986
Long-term clinical investigation of the hepatobiliary agents: 99mTc-HIDA and 99mTc-p-butyl-IDAN H Agha, A M Al-Hilli, N D Dahir, et al.Nuklearmedizin. Nuclear Medicine|August 1, 1997
[Cost minimization analysis for the definitive therapy of hyperthyroidism: comparison of goiter resection with radioiodine therapy]M Dietlein, L Geckle, T Overbeck, et al.Nuklearmedizin. Nuclear Medicine|August 1, 1997
[Simultaneous use of different nuclear medical examinations in Klippel-Trenaunay syndrome--vs. Proteus syndrome]T Rink, R P Baum, I Menzel, et al.Nuklearmedizin. Nuclear Medicine|February 12, 1998
[How great is radiation exposure in the area surrounding patients after administration ov 99mTc-sestamibi?]A Kurtaran, J Preitfellner, P Schaffarich, et al.Pageof 204